← Back to news

Markets

Box Just Made A Bold AI Move Inside The Enterprise Market

Y

Cognyte Software (CGNT) Just Hinted At Something Bigger For 2028

Y

Why NetApp (NTAP) Just Made A Strategic Move Enterprises May Notice Fast

Y

Is SS&C an Undervalued Quantum Computing Stock to Invest In?

Y

SPYM vs. NOBL: Which Stock ETF Is a Better Buy?

Y

Here is why Hewlett Packard is an Undervalued Quantum Computing Stock to Invest In

Y

Fidelity National (FIS): Most Undervalued Quantum Computing Stock to Invest In

Y

Why Sentiment Just Shifted Sharply In Favor Of Arrow Electronics (ARW)

Y

Accenture (ACN) Makes A Quiet Move Into One Of The Most Important Markets Ahead

Y

NXP Semiconductors (NXPI): A Cut To $230 Reveals A Bigger Debate

Y

Why Leidos Holdings (LDOS) Could Be Entering A New Growth Phase

Y

Qualcomm (QCOM) Makes A Strategic Bet That Could Matter More Than It Seems

Y

Akamai Technologies (AKAM): A $130 Target Suggests The Market May Be Missing Something

Y

Why Check Point Software (CHKP) Faces A More Complicated Outlook

Y

What to Know About This $9 Million Bond ETF Exit and What One Fund Bought Instead

Y

The Last Time Microsoft Stock Was This Cheap Was 2017

Y

Is The RealReal (REAL) a Worthy Investment?

Y

Jensen Huang Reveals Nvidia's Unique All-In Investment Approach: 'We Don't Pick Winners'

Y

2 Legendary ETFs, Built for Very Different Investors: SPY vs. QQQ

Y

Stifel Upgrades Onto Innovation to Buy With a Massive New Price Target: Did the Market Miss a Huge Semiconductor Signal?

Y

Here’s What Allows Evolv Technologies’ (EVLV) Compounding

Y

China's DeepSeek is raising funds at $10 billion valuation, The Information reports

Y

Netflix Stock Mauled As Video Streamer Faces Sluggish Growth Outlook

Y

China's Hesai announces lidar sensor able to detect colour for autonomous driving

Y

Is OneSpaWorld (OSW) a Misunderstood Stock?

Y

Tesla Earnings: What Robotaxi Updates Should Investors Expect?

Y

Here’s How Cedar Grove Capital Management Benefitted from Its Short Position in Hims & Hers Health (HIMS)

Y

I'm 62 with $1.2 million in investments, but I don’t own my home. Can I afford to leave my husband?

Y

Truist Adjusts Community Health Systems, Inc. (CYH) Outlook Within Broader Sector Update

Y

Logistics layoffs top 800 as contracts unwind across trucking, warehousing

Y

T-Mobile assumed with an Overweight at Morgan Stanley

Y

Wall Street indexes rally after Iran says Strait of Hormuz 'completely open'

Y

SAP price target lowered to $250 from $300 at TD Cowen

Y

Gold Heads For Fourth Weekly Gain

Y

M&T Bank price target raised to $235 from $233 at DA Davidson

Y

Are You Actually Getting No Tax on Social Security When You File Taxes This Year?

Y

Morgan Stanley Just Named Affirm Its Top Pick: Private Credit Fears Are Overdone and a May Catalyst Could Be Huge

Y

Should You Invest in F&G Annuities & Life (FG)?

Y

Sompo teams up with Zego as it joins $28m fundraising

Y

Kevin O'Leary got choked up sharing 4 investing rules his mom followed for 55 years to put two kids through college

Y

Multimedia retailer QVC Group begins Chapter 11 process

Y

RBC Flags Seasonal Pressures Impacting Karyopharm Therapeutics Inc. (KPTI) Short-Term Performance

Y

Evercore Maintains Positive Stance on MeiraGTx Holdings plc (MGTX) Amid Sector Revisions

Y

Morgan Stanley Updates Bicycle Therapeutics plc (BCYC) Outlook Amid Pipeline Refocus

Y

Jefferies Sees Reduced Upside for Arbutus Biopharma Corporation (ABUS) on Higher Appeal Probability

Y

Mizuho Sees Strong Risk-Reward in Corbus Pharmaceuticals Holdings, Inc. (CRBP) Near Cash Value

Y

Northland Highlights ARS Pharmaceuticals, Inc. (SPRY) Needle-Free Therapy as Major Innovation Driver

Y

Jefferies Sees Reduced Visibility for Replimune Group, Inc. (REPL) Following FDA Decision

Y

Evercore Adjusts Fortrea Holdings Inc. (FTRE) Valuation Following Updated Near-Term Assumptions

Y

Wolfe Highlights Differentiation Potential in Palisade Bio, Inc. (PALI) Clinical Profile

Y